Chronic myeloid leukemia (CML) is characterized by a reciprocal translocation between chromosome 9 and 22 in the hematopoietic stem cell that results in formation of the Philadelphia chromosome (Ph), encoding the BCR::ABL1 fusion gene [1]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.